• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Invasive Pulmonary Aspergillosis in Patients with Influenza Infection: A Retrospective Study and Review of the Literature

tetano

Editor, Senior Moderator
Clin Respir J. 2019 Jan 20. doi: 10.1111/crj.12995. [Epub ahead of print]
[h=1]Invasive Pulmonary Aspergillosis in Patients with Influenza Infection: A Retrospective Study and Review of the Literature.[/h] Huang L[SUP]1[/SUP], Zhang N[SUP]1,[/SUP][SUP]2[/SUP], Huang X[SUP]1[/SUP], Xiong S[SUP]1[/SUP], Feng Y[SUP]1[/SUP], Zhang Y[SUP]1[/SUP], Li M[SUP]1[/SUP], Zhan Q[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]INTRODUCTION:[/h] There has been a rapid increase in the number of influenza and invasive pulmonary aspergillosis (IPA) co-infection.
[h=4]OBJECTIVES:[/h] To explore the risk factors and predictors of a poor prognosis in influenza and IPA co-infection.
[h=4]METHODS:[/h] We included patients with confirmed influenza during the 2017 to 2018 influenza season and cases of influenza and IPA co-infection in the literature.
[h=4]RESULTS:[/h] A total of 64 patients with influenza infection were admitted to ICU. Of these patients, 18 were co-infected with IPA. Others were assigned to the control group (n=46). A total of 45 patients from the literature were added to the IPA group (n=63). A multivariate logistic regression suggested that influenza patients who were given steroids after ICU admission, who had a WBC of more than 10*10^9/L on ICU admission, and whose CT findings manifested as multiple nodules and cavities might have a higher risk of developing IPA. Compared to survivors, non-survivors had higher SOFA scores (16?4 points vs. 8?4 points, P<0.001), lower CD[SUB]4[/SUB] [SUP]+[/SUP] T cell counts on ICU admission [315 (83-466) cells/μl vs. 152 (50-220) cells/μl, P=0.031] and more requirement ECMO support [13 (50%) vs. 7 (18.9%), P=0.015].
[h=4]CONCLUSIONS:[/h] Influenza patients who are given steroids after ICU admission, who have WBCs of greater than 10*10^9/L on ICU admission, and whose CT imaging shows multiple nodules and cavities might have a high risk of IPA. Higher SOFA scores, CD[SUB]4[/SUB] [SUP]+[/SUP] T cell counts lower than 200 cells/μl on ICU admission and more ECMO requirement might be predictors of a poor prognosis. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.


[h=4]KEYWORDS:[/h] Clinical presentations; Influenza; Invasive pulmonary aspergillosis (IPA); Prognosis; Risk factor

PMID: 30661296 DOI: 10.1111/crj.12995
 
Back
Top Bottom